Skip to Content
  • Previous Rank5
  • Revenues ($M)$192,487
  • Revenue Percent Change6.2%
  • Profits ($M)$2,258
  • Profits Percent Change53%
  • Assets ($M)$56,563
  • Employees68,000
  • Market Value — as of March 31, 2017 ($M)$31,439

McKesson, the largest U.S. pharmaceutical distributor, continues to face obstacles as the tailwind from branded drug price inflation subsides and customers look elsewhere. But its management isn’t taking the news lying down. A series of acquisitions, ongoing restructuring, and a rash of new deals are helping lessen the blow, setting in motion a roller-coaster ride of a year. McKesson was founded in 1833 and is headquartered in San Francisco.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

John H. Hammergren
CEO Title
Chairman, President & Chief Executive Officer
Wholesalers: Health Care
HQ Location
San Francisco, CA
Years on Fortune 500 List23
Figures are for fiscal year ended March 31, 2016.

McKesson Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$192,4876.2%
Profits ($M)$2,25853%
Assets ($M)$56,563-
Total Stockholder Equity ($M)$8,924-
Market Value — as of March 31, 2017 ($M)$31,439-

Profit Ratios

Profit as % of Revenues1.2%
Profits as % of Assets4%
Profits as % of Stockholder Equity25.3%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)9.7
EPS % Change (from 2015)54.7%
EPS % Change (5 year annual rate)16.2%
EPS % Change (10 year annual rate)15.1%

Total Return

Total Return to Investors (2016)-28.3%
Total Return to Investors (5 year, annualized)13.3%
Total Return to Investors (10 year, annualized)11.6%